Dilution Protection. If the Corporation shall at any time pay a stock dividend or distribution on its Common Stock or if the Corporation shall at any time split, subdivide or combine the outstanding shares of its Common stock, the number of shares for which the Options granted hereunder may be exercised and the exercise price per share shall be adjusted proportionately. Any such adjustments shall be effective as of the record date for the split, subdivision or combination.
Dilution Protection. (a) In the event the Company shall (i) declare a dividend on its Common Stock in shares of Common Stock or make a distribution in shares of Common Stock, (ii) declare a stock split or reverse stock split of its outstanding shares of Common Stock, (iii) combine its outstanding shares of Common Stock into a smaller number of shares of Common Stock or (iv) issue by reclassification of its shares of Common Stock other securities (including any such reclassification in connection with a consolidation or merger in which the Company or any of its subsidiaries is the continuing corporation), then the number of shares of Common Stock of the Company, deliverable to Holder hereunder and the exercise price related thereto shall be adjusted so that the Holder shall be entitled to receive the kind and number of shares of Common Stock of the Company which the Holder has the right to receive, upon the happening of any of the events described above, with the respect to the shares of the Company stock which were otherwise deliverable pursuant hereto. An adjustment made pursuant to this paragraph shall become effective immediately after the effective date of such event;
Dilution Protection. Except for shares of Common Stock to be issued upon conversion of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, the Series C-3 Preferred Stock, the Series D Preferred Stock, any series of Series E Preferred Stock or the Series F Preferred Stock, and upon exercise of the Series D Warrants, Series E Warrants, the Founders’ Warrants, any other options or warrants listed on Schedule 4.5(b) hereof or any options, warrants or rights issued under the Equity Incentive Plan (including the stock purchase and exchange programs established thereunder and any options for shares of Series F Preferred Stock, created before, on or after the date hereof as contemplated by the Equity Incentive Plan), and any capital stock of the Company issued pursuant to Acquisitions approved by the Board of Directors as provided in Section 7.14 hereof, without a Supermajority Board Vote, neither the Company nor any of its Subsidiaries will (a) issue, sell, give away, transfer, pledge, mortgage, assign or otherwise dispose of, grant any rights (either preemptive or other) or options to subscribe for or purchase, enter into any agreements, or issue any warrants, providing for the issuance of, in any such case, any capital stock of the Company or any stock or securities convertible into or exchangeable for any capital stock of the Company or (b) designate any series of Preferred Stock of a class which has been authorized in the Company’s Amended and Restated Certificate of Incorporation; provided that the foregoing approval shall not be required for the issuance or transfer to the Company or any of its wholly-owned Subsidiaries of securities of any wholly-owned Subsidiary of the Company. Without the affirmative vote of 66-2/3% of the outstanding Common Stock and Preferred Stock (on an as converted basis), voting as a class, the Company will not authorize any additional class of capital stock or increase the number of shares of authorized capital stock from that set forth in Section 4.5 hereof or Schedule 4.5(a) hereto; provided, that the foregoing shall not apply to the authorization of any Series F Preferred Stock to be created after the date hereof as currently contemplated by the Equity Incentive Plan existing on the date hereof. The Company shall maintain such number of authorized and unissued shares of (v) Common Stock to be issued upon conversion of the Series A Preferred Stock, the Se...
Dilution Protection. The Plan contains detailed provisions for adjustments in the number and price of Shares for various corporate events, such as a change in capitalization, or a corporate transaction.
Dilution Protection. Intentionally omitted.
Dilution Protection. The Subscriber has been furnished with a copy of the Articles of Incorporation of the Company (including the Certificates of Designation with respect to the Series B and Series C Preferred Stock) and understands that the holder of the Series C Preferred Stock is entitled to anti-dilution protection with respect to any issuances of Common Stock occurring after the issuance of the Series C Preferred Stock on March 7, 2016.
Dilution Protection. CECONOMY undertakes to Convergenta, from today until the date on which the Capital In- crease through Contribution in Kind is entered in the commercial register responsible for CECONOMY (Registration Date) not to use approved capital (genehmigtes Kapital) or condi- tional capital (bedingtes Kapital) and not to propose any other capital measures to the Annual General Meeting. CECONOMY confirms that as at the date of conclusion of this Contribution Agreement, no instruments have been issued that are backed by conditional capital and that no resolution on the utilization of the existing approved capital has been passed.
Dilution Protection. Seller has been furnished with a copy of the Articles of Incorporation of Purchaser, as amended (including the Certificates of Designation with respect to the Series C Convertible Preferred Stock), and understands that the holder of Purchaser’s Series C Convertible Preferred Stock is entitled to anti-dilution protection with respect to any issuances of Dolphin Common Stock occurring after the issuance of the Series C Convertible Preferred Stock on March 7, 2016, as per the terms of such Articles of Incorporation and Certificate of Designation.
Dilution Protection. The Company will not and will not permit any of its Subsidiaries to (a) issue, sell, give away, transfer, pledge, mortgage, assign, or otherwise dispose of, (b) grant any rights (either preemptive or other) or options to subscribe for or purchase, or (c) enter into any agreements or issue any warrants providing for the issuance of, any of the capital stock of the Company or any of its Subsidiaries or any stock or any securities convertible into or exchangeable for any of the capital stock of the Company or any of its Subsidiaries except for the Warrant and the Warrant Stock. The Company will not transfer, pledge, mortgage, assign or otherwise dispose of any of its capital stock except for the pledge of its stock with respect to the Franklin Indebtedness. Except as contemplated hereby, the Company will not and will not permit any of its Subsidiaries to authorize any additional classes or series of capital stock nor will the Company increase the number of shares of authorized capital stock from that set forth in Section 2.5(a) hereof.
Dilution Protection. The number and kind of Shares issuable (or to be issued hereunder)shall be subject to adjustment from time to time upon the happening of certain events ("Adjustment Event"), as follows:
